News & Analysis as of

China Compliance Investigations

Thomas Fox - Compliance Evangelist

Daily Compliance News: July 28, 2025, The Where is Grasshopper when you need him Edition

Welcome to the Daily Compliance News. Each day, Tom Fox, the Voice of Compliance, brings you compliance-related stories to start your day. Sit back, enjoy a cup of morning coffee, and listen in to the Daily Compliance News....more

Wiley Rein LLP

Commerce Seeks Comments on UAS Imports in New Section 232 Investigation

Wiley Rein LLP on

On July 16, 2025, the U.S. Department of Commerce published a Federal Register notice soliciting public comments on an investigation into the national security impacts of imported unmanned aircraft systems (UAS or drones) and...more

Thomas Fox - Compliance Evangelist

Daily Compliance News: July 21, 2025, The More Reasons Not to Go to China Edition

Welcome to the Daily Compliance News. Each day, Tom Fox, the Voice of Compliance, brings to you compliance-related stories to start your day. Sit back, enjoy a cup of morning coffee, and listen in to the Daily Compliance...more

Snell & Wilmer

FARA's Pendulum: Shifts in Foreign Agent Regulation

Snell & Wilmer on

On her first day in office, Attorney General Pamela Bondi issued a memorandum signaling a significant shift in the Department of Justice’s (DOJ) approach to Foreign Agents Registration Act (FARA) enforcement. The memorandum...more

Pillsbury Winthrop Shaw Pittman LLP

New Congress, More Scrutiny? Preparing for Congressional Oversight and Investigations

With unified Republican control and President-elect Trump in the White House, the new 119th Congress is certain to launch a wave of oversight activities. Organizations should prepare now for a high-stakes and unpredictable...more

Health Care Compliance Association (HCCA)

NIH Disavows China Initiative, Offers ‘Trusted Asians’ Support But Cases, Questions Linger

In recent months, NIH signaled that it, in the words of Director Monica Bertagnolli, understands the “difficult climate for our valued Asian American, Asian immigrant and Asian research colleagues who may feel targeted and...more

Mintz

Three Key Takeaways from CFIUS's 2023 Annual Report

Mintz on

The Committee on Foreign Investment in the United States (CFIUS) released its statutorily mandated annual report to congress last month. While the report itself highlights several notable developments in 2023 (New Zealand and...more

A&O Shearman

Top challenges for white collar crime and investigations lawyers in 2024

A&O Shearman on

We asked our global white collar crime team for their views on the key challenges in 2024 for in‑house investigations teams and white collar crime lawyers, and how to manage the associated risks. Here is what they said. ...more

Foley & Lardner LLP

Leveraging the International Labor Organization’s Forced-Labor Indicators to Eradicate Forced Labor from Supply Chains

Foley & Lardner LLP on

The United States Customs and Border Protection (CBP) prioritizes enforcing rules against the use of forced labor and human trafficking. The CBP’s ramped-up enforcement of the Uyghur Forced Labor Prevention Act (UFLPA) is...more

Health Care Compliance Association (HCCA)

DOJ: Stanford FCA Case Involved Failures to Disclose Foreign Support From Seven Countries

Report on Research Compliance 20, no. 11 (November, 2023) It wasn't just China. China is among the countries whose support for Stanford University investigators wasn’t reported to five federal research funding agencies,...more

Seward & Kissel LLP

Seward & Kissel LLP Obtains Forum Non Conveniens Dismissal from Marshall Islands Supreme Court on Behalf of Sea Justice Ltd.

Seward & Kissel LLP on

In a recent decision filed August 2, 2023 in the Supreme Court of the Republic of the Marshall Islands (the RMI) Seward & Kissel LLP secured victory for its client, Sea Justice Ltd., in the action styled Symphony Shipholding...more

Health Care Compliance Association (HCCA)

NSF Suspends 18 Awards, Receives Repayments Related to Foreign Ties, Research Misconduct

One university lost 14 awards; another, four. An investigator was suspended governmentwide. A public institution paid back more than $850,000, while two others returned nearly a million dollars....more

American Conference Institute (ACI)

[Event] 13th West Coast Forum on FCPA Enforcement and Compliance - June 14th - 15th, San Francisco, CA

Hosted by American Conference Institute, the 13th West Coast Forum on FCPA Enforcement and Compliance returns for another exciting year, providing the opportunity to connect with decision-makers from your industry, gather...more

Faegre Drinker Biddle & Reath LLP

The $180 Million Chinese Coffee Case for Attempting to Manage Earnings

Last week, on December 16, 2020, Chinese-based coffee chain Luckin Coffee Inc. (“Luckin”) agreed to a $180 million settlement with the United States Securities and Exchange Commission (“SEC”). Luckin’s American Depositary...more

Thomas Fox - Compliance Evangelist

Where Else? JP Morgan Chase Investigation Into Hiring Practices Expands

One of the most dreaded questions in any Foreign Corrupt Practices Act (FCPA) investigation is: Where Else? By this I mean that if you have a systemic failure of internal controls in one geographic area it may well be that...more

Thomas Fox - Compliance Evangelist

GSK And Missed Red Flags In China

One of the questions that GlaxoSmithKline PLC (GSK) will have to face during the next few years of bribery and corruption investigations is how an allegedly massive bribery and corruption scheme occur in its Chinese...more

Thomas Fox - Compliance Evangelist

The Films Of Satyajit Ray And The GSK China Investigation: Both Game-Changers

If you are in London this week, I might suggest that you drop by the British Film Institute (BFI), which is celebrating the work of the Indian film maker, Satyajit Ray....more

The Volkov Law Group

The Real Implications Of The Glaxo Enforcement Action In China

The Volkov Law Group on

The headlines get worse and worse. More companies under investigation....more

Mintz - Health Care Viewpoints

Chinese Investigation of GlaxoSmithKlein Broadens as Details Emerge

In the weeks since our first post on the Chinese investigation of GlaxoSmithKlein (GSK) for alleged “widespread bribery of doctors” to induce the prescription of GSK’s drugs, more details have emerged about the bribery...more

NAVEX

Early Lessons from GSK’s China Bribery Investigation

NAVEX on

Earlier this week, GlaxoSmithKline PLC (GSK) said that some executives may have breached Chinese law. Chinese officials had previously released details of their bribery allegations against GSK and detained four of the...more

20 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide